InsightRX Helps Boone County Hospital Improve Patient Safety with Precision Dosing
Retrieved on:
Wednesday, June 1, 2022
Magnetic resonance, Precision medicine, Goal, Vancomycin, Time, AKI, Journal, Pharmacy, Infection, Akis, Doctor of Philosophy, CEO, Software, Partnership, FAO Major Fishing Areas, Physician, Acute kidney injury, Tinnitus, Method, Machine learning, Patient, Hospital, Risk, Boone Hospital Center, Review, Technology, Antimicrobial stewardship, SAN, CMS, Efficiency, Journal of Pharmacy Practice and Research, Patient safety, Pharmaceutical industry, Medical device
SAN FRANCISCO, June 1, 2022 /PRNewswire/ -- Today InsightRX, a healthcare technology company which provides cloud-based precision dosing support to guide treatment decisions, announced that Boone County Hospital, a 25-bed critical access hospital in Iowa, implemented model-informed precision dosing via its point-of-care InsightRX Nova platform to reduce acute kidney infections resulting in zero nephrotoxicity events. The hospital has also improved the number of patients achieving the desired therapeutic range for their antibiotic regimen by 27% in one year.
Key Points:
- SAN FRANCISCO, June 1, 2022 /PRNewswire/ -- Today InsightRX , a healthcare technology company which provides cloud-based precision dosing support to guide treatment decisions, announced that Boone County Hospital, a 25-bed critical access hospital in Iowa, implemented model-informed precision dosing via its point-of-care InsightRX Nova platform to reduce acute kidney infections resulting in zero nephrotoxicity events.
- In May 2019, Boone County Hospital implemented InsightRX Nova, a precision dosing platform that uses pharmacokinetic model-informed Bayesian forecasting, to standardize its therapeutic drug monitoring for four key antibiotics, including vancomycin.
- While many smaller hospitals assumed they would be unable to meet the new standard of treatment, Boone Hospital was already practicing next-generation precision dosing with its patients.
- "Boone County Hospital is a great example of how even smaller, more rural facilities can leverage model-informed precision dosing to have a significant impact on patient safety," said Sirj Goswami, PhD, co-founder and CEO of InsightRX.